Sinil Pharmaceutical Co., Ltd. (KOSDAQ: 012790)

Sinil Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	7,238	7,519	4,944	7,340	4,163	2,975
Short-Term Investments	23,320	15,900	18,410	13,530	10,430	10,608
Cash & Short-Term Investments	30,558	23,419	23,354	20,870	14,593	13,583
Cash Growth	82.87%	0.28%	11.90%	43.01%	7.44%	-0.72%
Accounts Receivable	20,001	21,878	23,420	20,588	20,910	21,535
Other Receivables	658.84	967.33	293.28	133.52	266.51	360.57
Receivables	20,660	22,845	23,713	20,721	21,192	21,969
Inventory	20,570	22,492	20,188	16,700	16,937	15,072
Prepaid Expenses	15.97	27.45	19.92	24.67	22.9	24.37
Other Current Assets	0.52	3.85	6.05	110.3	26.31	18.54
Total Current Assets	71,805	68,787	67,280	58,427	52,772	50,667
Property, Plant & Equipment	44,385	41,916	35,744	30,999	32,150	28,005
Long-Term Investments	865.82	839.01	966.42	1,512	1,509	1,520
Other Intangible Assets	1,789	1,810	1,870	1,801	1,320	1,135
Long-Term Accounts Receivable	0	-	-	-	-	-
Long-Term Deferred Tax Assets	2,255	2,097	1,944	1,804	2,510	1,974
Other Long-Term Assets	36,992	36,960	34,978	34,381	34,498	34,286
Total Assets	158,142	152,460	142,832	128,974	124,810	117,838
Accounts Payable	4,589	5,455	6,807	4,967	3,756	4,044
Accrued Expenses	969.45	901.6	824.11	734.16	877.02	1,277
Current Portion of Leases	160.24	165.01	135.5	133.75	125.94	122.81
Current Income Taxes Payable	1,397	267.59	2,105	486.48	572.36	1,189
Other Current Liabilities	7,140	7,355	6,088	5,702	5,055	4,445
Total Current Liabilities	14,256	14,145	15,959	12,023	10,387	11,078
Long-Term Leases	303.97	379.12	3.98	139.48	267.01	392.95
Other Long-Term Liabilities	801.75	646.79	1,031	1,228	1,308	1,282
Total Liabilities	17,595	17,565	19,554	15,777	17,326	16,593
Common Stock	5,993	5,993	5,771	5,609	5,451	3,950
Additional Paid-In Capital	1,170	1,170	1,170	1,170	1,170	2,671
Retained Earnings	134,339	128,688	117,118	106,663	100,940	94,695
Treasury Stock	-1,358	-1,358	-1,285	-1,180	-1,012	-1,005
Comprensive Income & Other	402.29	402.29	503.25	934.27	934.27	934.27
Shareholders' Equity	140,546	134,895	123,277	113,196	107,484	101,245
Total Liabilities & Equity	158,142	152,460	142,832	128,974	124,810	117,838
Total Debt	464.2	544.13	139.48	273.22	392.95	515.76
Net Cash (Debt)	30,094	22,875	23,214	20,597	14,200	13,068
Net Cash Growth	81.36%	-1.46%	12.71%	45.04%	8.67%	-4.49%
Net Cash Per Share	2603.66	1978.43	2006.89	1850.33	1263.32	1161.57
Filing Date Shares Outstanding	11.56	11.56	11.12	11.24	11.25	8.28
Total Common Shares Outstanding	11.56	11.56	11.12	11.24	11.25	8.28
Working Capital	57,548	54,643	51,321	46,403	42,386	39,589
Book Value Per Share	12158.43	11669.56	11082.32	10069.36	9550.53	12226.83
Tangible Book Value	138,757	133,085	121,407	111,395	106,164	100,110
Tangible Book Value Per Share	12003.67	11512.97	10914.20	9909.14	9433.25	12089.74
Land	2,094	2,094	2,094	2,094	2,094	2,094
Buildings	34,736	34,193	28,429	19,865	19,643	16,372
Machinery	48,209	47,680	17,654	6,877	7,885	8,057
Construction In Progress	4,174	125	4,994	1,463	1,534	150

Source: S&P Capital IQ. Standard template. Financial Sources.